Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adherence evaluation of co-formulated versus multiple-pill antiretroviral therapy in adults with suppressed HIV infection
2011-004935-30Phase 4Active
- Sponsor
- AULSS n. 2 Marca Trevigiana
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lamivudine, tenofovir disoproxil fumarate, abacavir, efavirenz, zidovudine and 4 more in human immunodeficiency virus infection (HIV) (2 arms), sponsored by AULSS n. 2 Marca Trevigiana. Started Mar 2012; status: active.
02
Drugs
lamivudinetenofovir disoproxil fumarateabacavirefavirenzzidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2011-004935-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004935-30.